In vitro studies show that TFPI2 expression inversely correlates with malignancy in cell lines like glioblastoma, lung cancer, prostate cancer, fibrosarcoma, pancreatic ductal adenocarcinoma, gastric cancer, breast cancer, amelanotic melanoma, and thyroid cancer cells [15]. The gene discussed is TFPI2; the disease is breast cancer.